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Abstract
Despite extensive research, the pathogenesis of neurodegenerative Alzheimer’s disease (AD) still eludes our
comprehension. This is largely due to complex and dynamic cross-talks that occur among multiple cell types throughout
the aging process. We present a mathematical model that helps define critical components of AD pathogenesis based on
differential rate equations that represent the known cross-talks involving microglia, astroglia, neurons, and amyloid-b (Ab).
We demonstrate that the inflammatory activation of microglia serves as a key node for progressive neurodegeneration. Our
analysis reveals that targeting microglia may hold potential promise in the prevention and treatment of AD.
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Introduction
Alzheimer’s disease (AD) is one of the most prevalent
neurodegenerative disorders associated with aging, causing
dementia and related severe public health concerns [1]. Despite
extensive research effort and progress, the pathogenesis of AD
remains incompletely understood, partly due to highly complex
and intertwined intercellular cross-talks taking place throughout
the aging process [2]. Consequently, despite limited treatment
options to manage and slow the progression of AD, no effective
cure is available.
Although the deposition of amyloid-b (Ab) peptides and
formation of senile plaques in the brain is the cardinal
morphological feature identifying the clinical phenotype of AD
[3,4], increasing clinical and basic studies suggest that inflamma-
tory activation of microglia may play an equally important role
during the initiation and progression of the disease [5]. Microglia
are resident innate immune macrophages within brain tissues,
capable of expressing pro-inflammatory mediators and reactive
oxygen species when activated by inflammatory signals including
amyloid-b (Ab) [6]. In healthy brains, together with quiescent
astroglia (Aq), resting microglia may adopt an anti-inflammatory
state (M2) and in turn foster neuron survival (Ns) and prevent
astroglia proliferation (Ap) [7,8]. As inflammatory signals (e.g. Ab)
gradually build, microglia may adopt an activated pro-inflamma-
tory state (M1), leading to Ap proliferation and neuron death (Nd)
[9,10,11]. Neuronal debris, amyloid-b (Ab), and/or proliferating
astroglia (Ap) may in turn further exacerbate the inflammatory
phenotype of M1 macroglia [12,13]. The multiple positive and
negative feedbacks among these cells are thus crucial for
neurodegeneration that eventually alters the neuronal structure
and function during the pathogenesis of AD (Figure 1).
Due to its multi-cellular components and complex nature,
conventional experimental approaches have failed to identify
critical underlying causes for AD, contributing to the lack of an
effective therapeutic treatment. Mathematical models can serve as
powerful tools to understand the molecular and cellular processes
that control complex diseases [14,15]. Indeed, there have been
several attempts to model the process of senile plaque formation
[16,17,18,19]. Specifically, these approaches focused on a
nucleation step that is coupled with rates for the irreversible
binding of Ab monomers to the fibril ends, the lateral aggregation
of filaments into fibrils, and fibril elongation through end-to-end
association. Other modeling efforts examined the signaling
cascade responsible for microglia migration and activation in
response to an initial inflammation-provoking stimulus involving
Ab [16,20].
However, no systematic modeling approaches have been
reported to examine the network cross-talks among microglia,
neuron, and astroglia, and the corresponding pathological
consequence. Here, we evaluate the dynamic network involving
multiple cross-talks among distinct states of microglia, astroglia,
and neurons through a mathematical model. Our approach has
led to an intriguing insight suggesting that microglia activation in
addition to a threshold for Ab may be the critical initiator for the
pathogenesis of AD.
Methods
Mathematical Method
We propose a sixteen pathway AD mechanism involving seven
species that is shown schematically in Fig. 1. The paths have rates
ai that implicitly represent the influences of intercellular signaling
along them. The mechanism is based on an assumption of
constant risk of neuronal death, i.e., a single event randomly
initiates cell death independently of the state of any other neuron
at any instant [21]. The spatiotemporal influence of diffusion is
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timescale than signal dispersion through chemotaxis.
The seven rate equations for the cell populations and the
number of Ab molecules in an arbitrary local volume can be
written through seven coupled rate equations, namely,
dNs=dt~a1 Aq{a2 Ap{a3 M1, ð1Þ
dNd=dt~{dNs=dt, ð2Þ
dAq

dt~a4 M2{a5 M1, ð3Þ
dAp

dt~{dAp

dt, ð4Þ
dM2=dt~(a6za11)Ns{a10 Ndz(a7za12)Aq
{a9 M1za14 M2{(a8za13)Ab,
ð5Þ
dM1=dt~{dM2=dt, and ð6Þ
dAb=dt~a15 Ns{a16 M2: ð7Þ
These relate the change in each cell population or the number
of Ab molecules at any instant to the values of all species at that
Table 2. Sensitivities of the cell types to the initial conditions.
Ns(0) Nd(0) Aq(0) Ap(0) M1(0) M2(0) Ab (0)
Value 10
4 10
2 10
5 10
3 10
3 10
5 10
3
S(Ns) 1 <0 <0 <0 20.2 0 <0
S(Nd) <01 <0 <00 . 2<0 <0
S(Aq) <0 <01 <0 20.2 <0 <0
S(Ap) <0 <0 <01 0 . 2<0 <0
S(M1) <00 . 2<0 <01 . 2<0 <0
S(M2) <0 20.2 <0 <0 20.2 1 <0
S(Ab) 1 <0 <0 <0 20.2 <0 <0
Initial values X(0) of the initial cell populations and the number of molecules of
Ab in an arbitrary local volume and orders of magnitude for the sensitivity
coefficients S(Nj, j=s,d)=d N j/d(X(0)) determined after 20 years for tenfold
perturbations, i.e., 106and 10
216, in these initial values.
doi:10.1371/journal.pone.0015176.t002
Figure 1. Schematic of the AD mechanism that incorporates
feedback influences from surviving and dead neurons, Ns and
Nd, quiescent and proliferating astroglia Aq and Ap, reactive
and normal microglia, M1 and M2, and Ab. The rates associated
with the pathways are included in Table 1.
doi:10.1371/journal.pone.0015176.g001
Table 1. Mathematical parameters describing the functional interactions among various cell types.
Rate 1/year Pathway S(Ns)S ( N d)S ( M 1)S ( M 2) Sensitivity
a1 10
25 Aq R Ns 50000 250000 26000 6000 Strong
a2 10
23 Ap R Nd 2500 500 260 60 Weak
a3 10
22 M1 R Nd 2200 200 235 35 Weak
a4 10
24 M2 R Aq 500 2500 150 2150 Weak
a5 10
22 M1 R Ap 233 1 21 Weak
a6 10
22 Ns R M2 500 2500 26000 6000 Weak
a7 10
24 Aq R M2 5000 25000 250000 50000 Strong
a8 10
22 Ab H M2 2400 400 5000 25000 Moderate
a9 10
22 M1 H M2 230 30 250 2250 Weak
a10 10
22 Nd R M1 288 9 0 290 Weak
a11 10
22 Ns H M1 500 2500 26000 6000 Moderate
a12 10
24 Aq H M1 5000 25000 250000 50000 Strong
a13 10
22 Ab R M1 2400 400 5000 25000 Moderate
a14 10
24 M2 H M1 5000 25000 250000 50000 Strong
a15 1N s R Ab 210 10 100 2100 Weak
a16 10
22 M2 H Ab 100 2100 21000 1000 Weak
ar 1M 2 H Ab 8 28 2100 100 Weak
The rates ai associated with the pathways of the AD mechanism, and the sensitivities of the Ns and Nd populations to variations in the values of ai. The values for the
sensitivity coefficients S(Nj, j=s, d)=d N j/dai are determined after 20 years for 62.5% perturbations in each ai value. A cell population is more sensitive to a change in a rate
that produces a larger value of |S(Nj)|. Positive S(Nj) imply that a rate contributes to an increase in Nj while a negative value entails a corresponding population decrease.
doi:10.1371/journal.pone.0015176.t001
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Aq,A p, and M1 populations with the pathway weights a1, a2, and
a3, respectively. Whereas Aq increases the rate of change of Ns,A p
and M1 decrease it. Equation (5) for the rate of change of the M2
population is the most complex, since it involves nine pathway
weights, and five cell populations and Ab. The conversion of Ns
into Nd is irreversible, whereas those of Aq and M2 into Ap and M1
are reversible.
The rates for each ai are specified, as shown in presented in
Table 1 for each pathway. Since the literature points to the path
Ns R Ab being dominant, we assume that it is also the fastest. Its
rate is set at 1/year, i.e., each year every Ns cell stimulates the
formation of a sustaining an Ab molecule. Likewise, since neuronal
survival decreases significantly once disease progresses, we assume
that the overall path M2 R Aq R Ns is slow so that the associated
rates a1 and a4 are also relatively the smallest. The other rates are
similarly specified in terms of their relative abilities to facilitate or
inhibit the formation of a cell or Ab molecule according to the
particular pathway. Next, we specify the initial composition of the
volume under consideration. These initial conditions for the seven
species are presented in Table 2.
Results
Our objective is to be able to describe neuropathogenesis during
AD in terms of the Ns and Nd populations. Hence, we first
determine the sensitivities of these cells to changes in the rates ai,
using the usual definition of the sensitivity coefficient,
SN j

~dNj

dai,j ~s, d: ð8Þ
The sensitivity coefficients for Ns,N d,M 1 and M2 cells,
presented in Table 1, are determined after 20 years for 62.5%
perturbations in each ai value. A cell population is more sensitive
Figure 2. Dynamic simulation of various cell populations
during the progression of Alzheimer’s disease. The (a) Ns (black),
M1 (red) and Ab (blue), and (b) Nd (black) and Ap (blue) populations over
20 years for the rates reported in Table 1. The removal rate ar stabilizes
the net number of Ab molecules after three years so that there is only a
gradual increase in Nd and corresponding decline in Ns thereafter. The
microglia populations are also consequently relatively stable.
doi:10.1371/journal.pone.0015176.g002
Figure 3. Dynamic variations of cell populations given distinct Ab removal rate. Variations in the (a) M1, (b) Ap, (c) Ab, and (d) Nd
populations over 20 years for three values of ar =1 6(black), 10
216(red), and 10
226(blue) the value reported in Table 1 for the Ab removal rate. As
ar decreases, there is an increase in neuropathogenesis so that all four populations increase.
doi:10.1371/journal.pone.0015176.g003
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Positive values for S(Nj) imply that a rate contributes to an increase
in Nj while a negative value implies that its influence leads to a
corresponding population decrease. The sensitivity analysis shows
that the Ns and Nd populations are most sensitive to the path Aq R
Ns, which increases neuronal survival and decreases neuron death.
Important paths that inhibit neuropathogenesis include Aq R M2,
Aq H M1 and M2 H M1, while those that enhance disease involve
M1 R Nd,A b H M2 and Ab R M1.
A similar analysis that perturbs the initial cell populations and
the number of Ab molecules tenfold is presented in Table 2. It
shows that, in comparison to the other species, the M1 population
is most sensitive to these substantial perturbations in the initial
amount of any species while Nd is only sensitive to the initial
amounts of M1 and M2. This implies an important role for
microglia during AD progression. The sensitivity coefficients S(M1)
and S(M2), also presented in Table 1, show that, as for Ns and Nd,
the dominant paths that inhibit neuropathogenesis by affirming
M2 and decreasing M1 are also Aq R M2,A q H M1 and M2 H
M1. Once again, paths 7 and 14 involving Ab, i.e., Ab H M2 and
Ab R M1 promote AD progression. The model suggests that
interventions aimed at decreasing a8 and a13, which involve M1,
M2 and Ab and contribute to AD progression, are the ones more
likely to diminish neuropathogenesis. This intuitive result empha-
sizes that decreasing the number of reactive microglia and
ensuring a sufficient population of quiescent astroglia is important
in treating AD.
The temporal variation in various species for the rates in Table 1
is illustrated in Fig. 2. Figure 2(a) presents the Ns,M 1 and Ab
populations over 20 years, and Fig. 2(b) the corresponding values
for Nd and Ap. Most notable is the influence of the removal rate ar,
which stabilizes the number of Ab molecules after three years.
Following that period, there is only a gradual increase in Nd that is
coupled with a corresponding decline in Ns. Consequently, the
microglia populations are also relatively stable. Therefore, the
rates in Table 1 should be considered as being representative of a
healthy population.
We examine the influence of varying ar on neuropathogeneis in
Fig. 3, which presents the M1,A p,A b and Nd populations over 20
years for three values of ar.A sar decreases, there is an increasing
neuronal death. Thus, all four populations, which are associated
with AD progression, increase. While microglia play an important
role in AD, Fig. 3 shows how the local Ab concentration plays a
critical role in initiating and promoting AD.
We investigate this further by varying a8 and a13. Figure 4
presents results for the M1,N d and Ab populations over 20 years
for three values of a13.A sa13 increases, the M1,A p and Nd
populations also increase, leading to an associated decrease in
neuronal survival, as illustrated through Eqs. (1) and (2) of the
mathematical model. A tenfold increase in a13 leads to a near
doubling in Nd after 20 years. As Ns decreases so does Ab, but the
smaller protein concentration is still sufficient to promote
neuropathogenesis among the smaller Ns population. Identical
results are obtained for similar variations in the rate a8 for Ab H
M2, since the sensitivity coefficients for each of M1 and Nd towards
paths 8 and 13 are identical.
Discussion
We present a mathematical model for neuropathogenesis during
AD that involves neurons, normal and reactive glial cells, and Ab.
It uses neuronal death as a surrogate for senile plaque formation.
By monitoring neuronal health, we are able to identify intuitive
strategies for interventions. In particular, the model suggests that
the most effective intervention is one that improves the inhibition
of reactive microglia and Ab by normal microglia, and ensuring a
sufficient population of quiescent astroglia. Overall, neuropatho-
genesis proceeds through the production of reactive microglia.
Our analysis is consistent with experimental data that indicate
that inflammation may be an early initiator for AD, long before
the apparent senile plaque formation [22,23]. It further reinforces
Figure 4. Dynamic variations of cell populations given distinct
impacts of Ab on M1 macrophages (the value of a13). Variations
in the (a) M1, (b) Nd and (c) Ab populations over 20 years for three
values of a13 =1 6(black), 106(red), and 506(blue) the value reported
in Table 1 for the path Ab R M1.A sa13 increases, M1 and Nd also
increase and, consequently, there is an associated decrease in neuronal
survival. This is also illustrated through Eqs. (1) and (2) of the
mathematical model.
doi:10.1371/journal.pone.0015176.g004
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earlier inflammatory signals and alterations involving microglia as
a key node so as to better define AD initiation and understand
mechanisms for effective prevention and treatment of the disease.
We realize that our mathematical analysis is an initial attempt to
examine AD and may not fully account for the associate
intertwined cellular communication pathways. Nevertheless, it
serves as a hypothesis provoking and building process that should
encourage integrated analyses of AD pathogenesis. Future
experimental data examining the cross-talks among microglia,
astroglia, and neurons will allow us to better refine our model and
implement realistic parameters in the rate equations.
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